Código QR

Variant Hypersensitivity Reaction (HSR) Presented with Persistent Dry Cough after Receiving Oxaliplatin in a Pancreatic Cancer Patient

Oxaliplatin, a third generation of platinum-based anti-neoplastic agent has been approved for colorectal cancer in both adjuvant and metastatic settings. In addition, oxaliplatin is also indicated for other gastrointestinal malignancies such as metastatic pancreatic cancer in combination with gemcit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jia Li, Jennifer Peccerillo, Kristen Kaley
Formato: Artigo
Lenguaje:Inglês
Publicado: Tehran University of Medical Sciences 2009-09-01
Colección:Iranian Journal of Allergy, Asthma and Immunology
Materias:
Acceso en línea:https://ijaai.tums.ac.ir/index.php/ijaai/article/view/252
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!